Warren Millken is attempting to take over BiotechCorporation. The worth of Biotech depends on the successor failure of several drugs under development. Warren doesnot know the actual (per share) worth of Biotech, but thecurrent owners of Biotech do know the actual worth of thecompany. Warren assumes that Biotech’s actual worth isequally likely to be between $0 and $100 per share. Biotechwill accept Warren’s offer if it exceeds the true worth of thecompany. For example, if the current owners think Biotechis worth $40 per share and Warren bids $50 per share, theywill accept the bid. If the current owners accept Warren’sbid, then Warren’s corporate strengths immediately increaseBiotech’s market value by 50%. How much should War-ren bid?
Warren Millken is attempting to take over BiotechCorporation. The worth of Biotech depends on the successor failure of several drugs under development. Warren doesnot know the actual (per share) worth of Biotech, but thecurrent owners of Biotech do know the actual worth of thecompany. Warren assumes that Biotech’s actual worth isequally likely to be between $0 and $100 per share. Biotechwill accept Warren’s offer if it exceeds the true worth of thecompany. For example, if the current owners think Biotechis worth $40 per share and Warren bids $50 per share, theywill accept the bid. If the current owners accept Warren’sbid, then Warren’s corporate strengths immediately increaseBiotech’s market value by 50%. How much should War-ren bid?
Step by step
Solved in 2 steps with 9 images